| Anthony M Alberico, MD | |
|
1600 Medical Center Dr, Suite B500, Huntington, WV 25701-3656 | |
| (304) 691-1787 | |
| (304) 691-8711 |
| Full Name | Anthony M Alberico |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 43 Years |
| Location | 1600 Medical Center Dr, Huntington, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174581409 | NPI | - | NPPES |
| 036528900 | Medicaid | FL | |
| B07880 | Other | VISTA FLORIDA | |
| 08437 | Other | BCBS FL | |
| 3810010513 | Medicaid | WV | |
| 206587 | Other | ARMED FLORIDA PIN #1851 |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cabell Huntington Hospital Inc | Huntington, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians And Surgeons, Inc | 2961315734 | 324 |
News Archive
Researchers at Johns Hopkins have succeeded in making flattened, football-shaped artificial particles that impersonate immune cells. These football-shaped particles seem to be better than the typical basketball-shaped particles at teaching immune cells to recognize and destroy cancer cells in mice.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2014.
Home cooked meals specifically designed for infants and young children, are not always better than commercially available baby foods.
Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."
› Verified 8 days ago
| Entity Name | University Physicians & Surgeons, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730183286 PECOS PAC ID: 2961315734 Enrollment ID: O20031107000331 |
News Archive
Researchers at Johns Hopkins have succeeded in making flattened, football-shaped artificial particles that impersonate immune cells. These football-shaped particles seem to be better than the typical basketball-shaped particles at teaching immune cells to recognize and destroy cancer cells in mice.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2014.
Home cooked meals specifically designed for infants and young children, are not always better than commercially available baby foods.
Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony M Alberico, MD 1600 Medical Center Dr, Suite B500, Huntington, WV 25701-3656 Ph: (304) 691-1787 | Anthony M Alberico, MD 1600 Medical Center Dr, Suite B500, Huntington, WV 25701-3656 Ph: (304) 691-1787 |
News Archive
Researchers at Johns Hopkins have succeeded in making flattened, football-shaped artificial particles that impersonate immune cells. These football-shaped particles seem to be better than the typical basketball-shaped particles at teaching immune cells to recognize and destroy cancer cells in mice.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2014.
Home cooked meals specifically designed for infants and young children, are not always better than commercially available baby foods.
Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."
› Verified 8 days ago
Rida S Mazagri, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Center Drive, Suite B500, Huntington, WV 25701 Phone: 304-691-1787 Fax: 304-691-8711 | |
Dr. Sajeel Rehmat Khan, M.D Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Center Dr Ste B500, Huntington, WV 25701 Phone: 304-691-1787 | |
Dr. Richard A. Coulon, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1600 Medical Center Dr., Suite G-500, Huntington, WV 25701 Phone: 304-691-1787 Fax: 304-691-8711 | |
Dwight Saulle, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2860 3rd Ave, Suite 10, Huntington, WV 25702 Phone: 304-525-6825 Fax: 304-525-0300 | |
Dr. J. Paul Muizelaar, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Center Drive, Suite B500, Huntington, WV 25701 Phone: 304-691-1787 Fax: 304-691-8711 | |
Bryan R. Payne, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1340 Hal Greer Blvd, Huntington, WV 25701 Phone: 304-399-2889 Fax: 304-399-2881 |